VERTEX PHARMACEUTICALS EXEC SAYS CYSTIC FIBROSIS PORTFOLIO HAS ABOUT 9% EXPOSURE TO MEDICARE AND ABOUT 23% EXPOSURE TO MEDICAID - GOLDMAN SACHS CONFERENCE

Reuters · 06/10 18:57

Please log in to view news